MedTrace Logo

Inflammatory Biomarkers in Psychogenic Non-epileptic Seizure

NCT05571371 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2022-10-07

No results posted yet for this study

Summary

1. Evaluation of the role of TRAIL and MCP-2 in differentiation between epileptic seizure and psychogenic non-epileptic seizure.
2. Possible role to predict the prognosis of patients with epileptic seizure.

Conditions

  • Localization-Related (Focal) (Partial) Idiopathic Epilepsy and Epileptic Syndromes With Seizures of Localized Onset
  • TRAIL: Tumor Necrosis Factor Related Apoptosis Inducing Ligand MCP-2
  • MCP-2: Monocyte Chemo-attractant Protein-2

Interventions

OTHER

Measuring inflammatory serum biomarkers

Measuring inflammatory serum biomarkers

Sponsors & Collaborators

  • Esraa Mostafa Ahmed Abdel Aal

    lead OTHER

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-10-31
Primary Completion
2024-10-31
Completion
2024-11-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05571371 on ClinicalTrials.gov